| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000031433 |
| Receipt No. | R000035835 |
| Official scientific title of the study | 5-aminolevulinic acidphotodynamic therapy for cervical intraepithelial neoplasia |
| Date of disclosure of the study information | 2019/04/01 |
| Last modified on | 2018/02/22 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | 5-aminolevulinic acidphotodynamic therapy for cervical intraepithelial neoplasia | |
| Title of the study (Brief title) | 5-ALA-PDT for CIN | |
| Region |
|
|
| Condition | ||
| Condition | cervical intraepithelial neoplasia(CIN) | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | to investigate safety and efficacy of 5-ALA-PDT in patients with cervical intraepithelial neoplasia |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | safety(topical pain,erosion and overall status):at each PDT and 12 and 24weeks after last PDT
|
| Key secondary outcomes | Complete Response(CR) rate: 12 and 24weeks after last PDT
Treatment time |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 1 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Local administration of aminolevulinic acid jelly 2-3hours before PDT
PDT: irradiation for a red light of 635nm for 3-6minutes (total 100J/m2) |
||
| Interventions/Control_2 | |||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1)pathological diagnosis within 3months of the registration of this clinical trial
2)20-50 years-old and premenopausal female 3)ECOG Performance Status(PS) 0-2 4)Patients with organ function is maintained sufficiently 5)Patients with written consent of this clinical trial 6)outpatients |
|||
| Key exclusion criteria | 1)patients with porphyrin hypersensitivity
2)patients with Porphyrias 3)severe drug allergy 4)patients who use a drug causing photosensitivity 5)the patients with other malignant tumors 6)patient with uncontrolled infection 7)patients with myocardial infarction within 6months 8)patients with severe underlying disease 9)patients with severe mental disorders 10)gravida and lactational woman 11)patients judged by investigators as inappropriate to this study |
|||
| Target sample size | 10 | |||
| Research contact person | |
| Name of lead principal investigator | Masato Kita |
| Organization | Kansai Medical University |
| Division name | Obstetrics and gynecology |
| Address | 2-3-1, Shinmachi, Hirakata-shi, Osaka |
| TEL | 072-804-0101 |
| kitamas@hirakata.kmu.ac.jp | |
| Public contact | |
| Name of contact person | Yoji Hisamatsu |
| Organization | Kansai Medical University |
| Division name | Obstetrics and gynecology |
| Address | 2-3-1, Shinmachi, Hirakata-shi, Osaka |
| TEL | 072-804-0101 |
| Homepage URL | |
| hisamayj@kouri.kmu.ac.jp | |
| Sponsor | |
| Institute | Kansai Medical University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | SBI pharmaceutical Co.,Ltd.
Tsukada Medical Reseach Co.,Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 関西医科大学付属病院/Kansai Medical University Hospital |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035835 |